Search

everythinglearnresearchcommunity

for

Search:↓

Microneedling with triamcinolone helps hair regrowth in ophiasis alopecia areata.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Trichoscopy shows black dots, yellow dots, and empty follicles are common in Alopecia Areata, with broken and exclamation mark hair as typical patterns.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Levofloxacin may cause skin discoloration and hair loss as side effects.

The document says how to diagnose and treat hair loss from alopecia areata, but there's no cure and treatments vary.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

No link between scalp patterns and alopecia severity in children, but more severe cases often had nail abnormalities.

Detailed history and physical examination are crucial for diagnosing hair loss.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Transverse scalp biopsy sections help diagnose different alopecias by showing hair follicle details and inflammation patterns.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Two siblings both had a rare case of alopecia areata at the same time.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

Portraits show women's hairlines have moved forward over time, suggesting changes in the occurrence of frontal hair loss.

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

Scalp Roller therapy helped improve hair growth in patients with hard-to-treat alopecia areata.